Neurobehavioral Disorders
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
Neurobehavioral Disorders
HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.
Neurobehavioral Disorders
Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.
Neurobehavioral Disorders
The influence of gut microbiota extends to the brain via neuroinflammation, resulting in symptoms associated with major depressive disorder.
Neurobehavioral Disorders
The Food and Drug Administration (FDA) has granted Fast Track designation to an investigational intranasal formulation of racemic ketamine for the potential treatment of acute suicidal ideation and behavior in patients with major depressive disorder.
Neurobehavioral Disorders
Patients with psychotic depression who experienced an illness relapse while receiving placebo also had a decline in cortical thickness, emphasizing the essential role antipsychotics play in treating disorders where psychosis is present.
Neurobehavioral Disorders
Sixty percent of patients responded to treatment.
Neurobehavioral Disorders
There was insufficient evidence to recommend screening in children aged 11 and younger.
Neurobehavioral Disorders
The study provides strong evidence for the utility of resting-state fMRI measures in predicting the development of attentional or mood disorders in children.
Neurobehavioral Disorders
The drug was found to work quickly in patients with clinical major depression.